David H. Persing, EVP, Chief Med/Tech Officer at CEPHEID (CPHD), sold 15,242 shares at $52.03 ($785K) on 2014-10-28, disclosed to the SEC on 2014-10-28.
Scheduled sale ($785k) by EVP, Chief Med/Tech Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.08 | 128 | $6K | 0.8% |
| 2 | $50.08 | 114 | $6K | 0.7% |
| 3 | $51.00 | 5,000 | $255K | 32.5% |
| 4 | $51.51 | 5,000 | $258K | 32.8% |
| 5 | $52.03 | 5,000 | $260K | 33.1% |
| Total | $51.49 avg | 15,242 |
| $785K |
| 100% |
| Filing → |
| CPHD | SELL | 2014-12-02 | $837K | — | Filing → |
| CPHD | SELL | 2014-12-01 | $4.1M | — | Filing → |
| CPHD | SELL | 2014-11-17 | $273K | — | Filing → |